Further analysis showed that a SETD2 deleterious mutation was an independent factor influencing MSI-H in colorectal carcinoma (P < 0.0001) and stomach adenocarcinoma (P = 0.003) (Fig. 3B). Here, SETD2 is linked to colorectal carcinoma.